Introduction:
Catalent plans for the opening of new facility. This expansion will further increase the clinical supply network.
Features:
The new construction will support the growing demand for pharmaceutical and biopharmaceutical customers for integrated development, clinical packaging, and distribution solutions.
The new facility covers an area of 24,000-square-foot build within the early-phase oral drug product center of excellence, which is dedicated to support clinical studies in phases 1-3. In addition, the facility enables to offer end-to-end services consisting supply management, primary and secondary packaging and labeling, storage, distribution, returns and destruction.
The clinical supply services handles a broad range of international compliance and distribution requirements to support global clinical trials across U.S., U.K., Germany, Singapore, Japan and China.
The new full-service facility of development center will better serve customers not only on the West Coast of the U.S. and Canada but allover the world.
Specifications:
Name | Catalent |
Type | New Construction |